Related Experiment Video
Updated: Aug 2, 2025

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
Published on: January 10, 2025
Differentiating invasive thymic epithelial tumors from mediastinal lung cancer using spectral CT parameters
Liangna Deng1,2,3,4, Jingjing Yang1,2,3,4, Mengyuan Jing1,2,3,4
1Second Clinical School, Lanzhou University, Lanzhou, China.
Purpose:
The purpose of the study was to explore the importance of quantitative characteristics of spectral CT between invasive thymic epithelial tumors (TETs) and mediastinal lung cancer.
Methods:
We analyzed 54 patients (28 with invasive TETs and 26 with mediastinal lung cancer) who underwent spectral CT. During the arterial and venous phase, we measured the CT70keV, effective atomic number (Zeff), iodine concentration (IC), and water concentration (WC) and calculated the slope of the spectral curve (K100keV). We compared the clinical findings and spectral CT parameters of both groups and performed receiver operating characteristic analysis to evaluate the diagnostic efficacy and the optimal cutoff values of the spectral CT parameters.
Results:
During the AP and VP, the CT70keV, Zeff, IC, and K100keV were significantly higher in patients with invasive TETs than those in patients with mediastinal lung cancer (p < 0.05). WC was not statistically significantly different between the two groups (p > 0.05). ROC curve analysis revealed that all quantitative parameters combined in the AP and VP provided the best diagnostic performance in identifying invasive TETs from mediastinal lung cancer (AUC = 0.88, p = 0.002, sensitivity = 0.89 and specificity = 0.77). The cutoff values in the AP for CT70keV, IC, Zeff, and K100keV to differentiate invasive TETs from mediastinal lung cancer were 75.55, 15.86, 8.45, and 1.71, respectively. The cutoff values in the VP for CT70keV, IC, Zeff, and K100keV to differentiate them were 67.06, 15.74, 8.50, and 1.81, respectively.
Conclusions:
Spectral CT imaging has potential value in the differential diagnosis of invasive TETs and mediastinal lung cancer.

